glp 1 novo nordisk products inks Ascendis deal to develop long-acting GLP-1, other metabolic drugs Novo Nordisk hikes full-year forecast
Description
Free Ozempic tracker app for iPhone, Android, and web
PlexusDx compounded semaglutide and tirzepatide injections are HSA and FSA eligible, making precision weight loss therapy more accessible to patients managing obesity
Get your baseline with Weight Biology Kit.
Pfizer's obesity pill danuglipron has not progressed to Phase 3 trials and is not approved in the UK
